Xanthine
Xanthine is a purine base found in most human body tissues and fluids, as well as in other organisms. Several stimulants are derived from xanthine, including caffeine, theophylline, and theobromine.
Xanthine is a product on the pathway of purine degradation.
- It is created from guanine by guanine deaminase.
- It is created from hypoxanthine by xanthine oxidoreductase.
- It is also created from xanthosine by purine nucleoside phosphorylase.
Use and production
Xanthine is used as a drug precursor for human and animal medications, and is produced as a pesticide ingredient.Clinical significance
Derivatives of xanthine are a group of alkaloids commonly used for their effects as mild stimulants and as bronchodilators, notably in the treatment of asthma or influenza symptoms. In contrast to other, more potent stimulants like sympathomimetic amines, xanthines mainly act to oppose the actions of adenosine, and increase alertness in the central nervous system.Toxicity
Methylxanthines, which include caffeine, aminophylline, IBMX, paraxanthine, pentoxifylline, theobromine, theophylline, and 7-methylxanthine, among others, affect the airways, increase heart rate and force of contraction, and at high concentrations can cause cardiac arrhythmias. In high doses, they can lead to convulsions that are resistant to anticonvulsants. Methylxanthines induce gastric acid and pepsin secretions in the gastrointestinal tract. Methylxanthines are metabolized by cytochrome P450 enzymes in the liver.If swallowed, inhaled, or exposed to the eyes in high amounts, xanthines can be harmful, and they may cause an allergic reaction if applied topically.
Pharmacology
In in vitro pharmacological studies, xanthines act as both competitive nonselective phosphodiesterase inhibitors and nonselective adenosine receptor antagonists. Phosphodiesterase inhibitors raise intracellular cAMP, activate PKA, inhibit TNF-α synthesis, and leukotriene and reduce inflammation and innate immunity. Adenosine receptor antagonists inhibit sleepiness-inducing adenosine.However, different analogues show varying potency at the numerous subtypes, and a wide range of synthetic xanthines have been developed searching for compounds with greater selectivity for phosphodiesterase enzyme or adenosine receptor subtypes.
| Name | R1 | R2 | R3 | R8 | IUPAC nomenclature | Found in |
| Xanthine | H | H | H | H | 3,7-Dihydro-purine-2,6-dione | Plants, animals |
| 7-Methylxanthine | H | H | CH3 | H | 7-methyl-3H-purine-2,6-dione | Metabolite of caffeine and theobromine |
| Theobromine | H | CH3 | CH3 | H | 3,7-Dihydro-3,7-dimethyl-1H-purine-2,6-dione | Cacao, yerba mate, kola, guayusa |
| Theophylline | CH3 | CH3 | H | H | 1,3-Dimethyl-7H-purine-2,6-dione | Tea, cacao, yerba mate, kola |
| Paraxanthine | CH3 | H | CH3 | H | 1,7-Dimethyl-7H-purine-2,6-dione | Animals that have consumed caffeine |
| Caffeine | CH3 | CH3 | CH3 | H | 1,3,7-Trimethyl-1H-purine-2,6-dione | Coffee, guarana, yerba mate, tea, kola, guayusa, Cacao |
| 8-Chlorotheophylline | CH3 | CH3 | H | Cl | 8-Chloro-1,3-dimethyl-7H-purine-2,6-dione | Synthetic pharmaceutical ingredient |
| 8-Bromotheophylline | CH3 | CH3 | H | Br | 8-Bromo-1,3-dimethyl-7H-purine-2,6-dione | Pamabrom diuretic medication |
| Diprophylline | CH3 | CH3 | C3H7O2 | H | 7--1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione | Synthetic pharmaceutical ingredient |
| IBMX | CH3 | C4H9 | H | H | 1-Methyl-3--7H-purine-2,6-dione | |
| Uric acid | H | H | H | O | 7,9-Dihydro-1H-purine-2,6,8-trione | Byproduct of purine nucleotides metabolism and a normal component of urine |